Eli Lilly and Co (FRA:LLY0) Inventories, Work In Process: €7,314 Mil (As of Mar. 2026)


FRA:LLY0 Eli Lilly and Co FRA:LLY0
98 GF Score
Price €26.40
GF Value €30.80
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Eli Lilly and Co Inventories, Work In Process?

Eli Lilly and Co FRA:LLY0 +6.45% 98 Inventories, Work In Process is €7,314 Mil as of Mar. 2026. GuruFocus rates FRA:LLY0 with a GF Score™ of 98/100 and a GF Value™ of €30.80 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Work in process is the part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. Eli Lilly and Co's work in process for the quarter that ended in Mar. 2026 was €7,314 Mil.

Eli Lilly and Co Inventories, Work In Process Historical Data

* Premium members only.

The historical data trend for Eli Lilly and Co's Inventories, Work In Process can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Eli Lilly and Co Inventories, Work In Process Chart

Eli Lilly and Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Work In Process
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,099.84 2,452.23 2,978.97 3,799.95 6,988.28

Eli Lilly and Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Work In Process Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,899.08 5,643.30 6,197.87 6,988.28 7,314.44
FRA:LLY0
98GF Score
Eli Lilly and Co FRA:LLY0
Inventories, Work In Process is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Eli Lilly and Co Inventories, Work In Process Calculation

That part of a manufacturer's inventory that is in the production process and has not yet been completed and transferred to the finished goods inventory. This account contains the cost of the direct material, direct labor, and factory overhead placed into the products on the factory floor. A manufacturer must disclose in its financial statements the cost of its work-in-process as well as the cost of finished goods and materials on hand.

What does a Inventories, Work In Process of €7,314 Mil mean?
Eli Lilly and Co (FRA:LLY0) has a Inventories, Work In Process of €7,314 Mil as of Mar. 2026. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Eli Lilly and Co and its competitors.
Is Eli Lilly and Co's Inventories, Work In Process too high?
Eli Lilly and Co's current Inventories, Work In Process is €7,314 Mil. Overall, Eli Lilly and Co has a GF Score™ of 98/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Eli Lilly and Co's Inventories, Work In Process compare to JNJ and ABBV?
Eli Lilly and Co's Inventories, Work In Process of €7,314 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Work In Process for a Drug Manufacturers company?
A good Inventories, Work In Process depends on the Drug Manufacturers industry context. However, Inventories, Work In Process should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Work In Process mean?
A high Inventories, Work In Process can signal that a stock is expensive relative to its fundamentals. Work in progress is the portion of inventory containing goods that are unfinished. View historical data on Eli Lilly and Co and its competitors. Eli Lilly and Co's current Inventories, Work In Process is €7,314 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eli Lilly and Co stock overvalued right now?
Based on GuruFocus' analysis, Eli Lilly and Co (FRA:LLY0) is currently considered Modestly Undervalued. The stock's GF Value™ is €30.80, compared to a current price of €26.40 — trading 14.3% below its estimated fair value. The current Inventories, Work In Process is €7,314 Mil. Eli Lilly and Co's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Work In Process calculated?
Inventories, Work In Process is calculated from a company's financial statements. For Eli Lilly and Co (FRA:LLY0), the current Inventories, Work In Process is €7,314 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Eli Lilly and Co (FRA:LLY0) Overvalued in 2026?

Based on GuruFocus' analysis, Eli Lilly and Co stock appears to be undervalued. The current stock price of €26.40 is trading 14.3% below its estimated GF Value™ of €30.80. GuruFocus considers Eli Lilly and Co to be Modestly Undervalued.

Key valuation signals for FRA:LLY0:

  • Inventories, Work In Process: €7,314 Mil
  • GF Value™: €30.80 vs. price of €26.40 (14.3% below fair value)
  • GF Score™: 98/100 with 6 warning signs

No single metric tells the full story. See the FRA:LLY0 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Eli Lilly and Co Business Description

Address Lilly Corporate Center, Indianapolis, IN, USA, 46285
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
98GF Score

Get the complete analysis for FRA:LLY0

Inventories, Work In Process is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€26.40
Price
€30.80
GF Value